AGP Executive Report
Last update: 8 hours agoPTSD & THC/CBD Research: Charité researchers report in Nature Medicine that a prescription THC-containing treatment helped more than half of participants with PTSD nightmares, with over a third seeing complete disappearance. Dementia Agitation Trial: A Phase 2 LIBBY study is testing an oil-based THC/CBD combo for agitation in advanced dementia patients, with results recently presented. Obesity Drug Pipeline: Corbus says the last patient completed Phase 1b CANYON-1 for CRB-913, an oral CB1 cannabinoid inverse agonist designed to limit brain penetration while supporting weight loss. Medical Cannabis Access & Rights: A Maryland appeals court ruled police can search a vehicle after smelling cannabis when officers know all occupants are under 21, creating a key exception to the general odor-only search limits. Policy & Industry Watch: Louisiana residents still must petition to clear old records under a delayed Clean Slate Act implementation, while multiple states/provinces continue debating hemp THC rules and bans. Market/Business Angle: States are exploring converting closed cannabis grows into data centers, leveraging existing power and cooling infrastructure.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
